In patients with renal impairment, rocuronium and sugammadex are the primary choice for reversing neuromuscular blockade, ...

According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.

The researchers also identified an eGFR threshold of 38 mL/min/1.73m², below which patients were at increased risk of developing moderate to severe renal dysfunction at 1 year. Patients ...